Innovation
2 patent families (1 granted) — focus: Chemistry & metallurgy; filing pace dormant. Cited 15 times.
| Year | Filings |
|---|---|
| 2017 | 1 |
Investor mix
8 investors on record; lead investors include Novartis, Gold Hill Capital, Novartis Venture Fund, Yasuda Enterprise Development.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 38% |
| Private equity | 3 | 38% |
| Other / undisclosed | 2 | 25% |